Condition 101 About Spinal Muscular Atrophy Type 3

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Spinal Muscular Atrophy Type 3

View All Doctors

Latest Advances On Spinal Muscular Atrophy Type 3

  • Condition: Spinal Muscular Atrophy Type 3
  • Journal: The neurologist
  • Treatment Used: Nusinersen
  • Number of Patients: 1
  • Published —
This case report describes a patient with spinal muscular atrophy type 3 that was treated using nusinersen.
  • Condition: Spinal Muscular Atrophy
  • Journal: Orphanet journal of rare diseases
  • Treatment Used: Nusinersen
  • Number of Patients: 123
  • Published —
In this study, researchers evaluated the outcomes of using nusinersen for the treatment of spinal muscular atrophy in children.
View All Latest Advances

Clinical Trials For Spinal Muscular Atrophy Type 3

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 100
  • Start Date: January 2021
Outcome Measures and Biomarkers in a Cohort of Spinal Muscular Atrophy Type III/ IV Patients
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 73
  • Start Date: August 16, 2018
A Prospective, Multi-center, Observational Study of the Safety, Tolerability and Effectiveness of SPINRAZA® (Nusinersen) in Adult Patients With Spinal Muscular Atrophy
View All Clinical Trials